• RNAi screen indicates widespread biological function for human natural antisense transcripts.
• Evidence for natural antisense transcript-mediated inhibition of microRNA function.
• Regulatory roles of natural antisense transcripts.
• Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase.
• A novel RNA transcript with antiapoptotic function is silenced in fragile X syndrome.
• List of Publications

Mohammad A. Faghihi, M.D., Ph.D., is an Assistant Professor at The Department of Psychiatry & Behavioral Sciences at the University of Miami, Miller School of Medicine. Dr. Faghihi will also serve as a member of the Center for Therapeutic Innovation at the John P. Hussman Institute for Human Genomics.  He received his medical doctorate (M.D.) degree from Shiraz University of Medical Sciences, Iran in 1994. He received his Ph.D. degree in Biomedical Sciences at the Karolinska Institute, Stockholm, Sweden in 2009. He served as a Senior Staff Scientist at the Department of Neuroscience at the Scripps Research Institute, Florida, before joining University of Miami. Dr. Faghihi is an expert in the field of RNA genetics, interested in non-coding RNA, particularly natural antisense transcripts and their involvement in neurological disorders such as Alzheimer's disease, Parkinson's disease, Multiple Sclerosis and Fragile X Syndrome.